Taken together, we identified for the first time genetic alterations in EIF3A in ccRCC and found a clear relationship between alterations leading to an increase in EIF3A levels and worse clinical characteristics, including survival. Here, EIF3A is linked to nonpapillary renal cell carcinoma.